APEX Biologix entered into a know-how license agreement with Mayo Clinic to jointly develop new regenerative medicine products.
Under the agreement, Mayo Clinic will license its know-how to APEX Biologix, enabling the two organizations to collaborate on the development of new therapies that can potentially transform the treatment of musculoskeletal disease including acute injuries and chronic disease in joints and spine.
This collaboration will leverage Mayo Clinic’s expertise in clinical research and patient care, as well as APEX Biologix’s technology and therapies. This partnership will allow accelerated development of new regenerative medicine products to the patient market more efficiently.
Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit missions in patient care, education and research.
Source: Apex Biologix
APEX Biologix entered into a know-how license agreement with Mayo Clinic to jointly develop new regenerative medicine products.
Under the agreement, Mayo Clinic will license its know-how to APEX Biologix, enabling the two organizations to collaborate on the development of new therapies that can potentially transform the treatment of...
APEX Biologix entered into a know-how license agreement with Mayo Clinic to jointly develop new regenerative medicine products.
Under the agreement, Mayo Clinic will license its know-how to APEX Biologix, enabling the two organizations to collaborate on the development of new therapies that can potentially transform the treatment of musculoskeletal disease including acute injuries and chronic disease in joints and spine.
This collaboration will leverage Mayo Clinic’s expertise in clinical research and patient care, as well as APEX Biologix’s technology and therapies. This partnership will allow accelerated development of new regenerative medicine products to the patient market more efficiently.
Mayo Clinic has a financial interest in the technology referenced in this press release. Mayo Clinic will use any revenue it receives to support its not-for-profit missions in patient care, education and research.
Source: Apex Biologix
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.